AG˹ٷ

STOCK TITAN

HeartCore Reports 2024 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

HeartCore Enterprises (HTCR) reported its 2024 financial results, showing a 39% revenue increase to $30.4 million year-over-year. The company's gross profit grew 121% to $17.8 million. However, HeartCore recorded a $7.2 million impairment of goodwill related to its Sigmaways subsidiary, leading to a net loss of $5.2 million for the year.

The company maintained its market leadership in Japan for the ninth consecutive year and implemented several strategic initiatives, including expanding its CMS platform to a SaaS model and transitioning to multi-year contracts. HeartCore plans to expand its Go IPO consulting business into South Korea, with a seminar scheduled for September 2025.

The company ended 2024 with $2.1 million in cash and cash equivalents, up from $1.0 million in 2023, and reported adjusted EBITDA of $7.3 million compared to $(3.6) million in the previous year.

HeartCore Enterprises (HTCR) ha riportato i risultati finanziari del 2024, mostrando un aumento del fatturato del 39% a 30,4 milioni di dollari rispetto all'anno precedente. Il profitto lordo dell'azienda è cresciuto del 121% a 17,8 milioni di dollari. Tuttavia, HeartCore ha registrato un'imparità di goodwill di 7,2 milioni di dollari relativa alla sua controllata Sigmaways, portando a una perdita netta di 5,2 milioni di dollari per l'anno.

L'azienda ha mantenuto la sua leadership di mercato in Giappone per il nono anno consecutivo e ha implementato diverse iniziative strategiche, tra cui l'espansione della sua piattaforma CMS a un modello SaaS e la transizione verso contratti pluriennali. HeartCore prevede di espandere il suo business di consulenza Go IPO in Corea del Sud, con un seminario programmato per settembre 2025.

L'azienda ha chiuso il 2024 con 2,1 milioni di dollari in contante e equivalenti, in aumento rispetto a 1,0 milione di dollari nel 2023, e ha riportato un EBITDA rettificato di 7,3 milioni di dollari rispetto a (3,6) milioni di dollari dell'anno precedente.

HeartCore Enterprises (HTCR) reportó sus resultados financieros de 2024, mostrando un aumento del 39% en los ingresos a 30,4 millones de dólares en comparación con el año anterior. La ganancia bruta de la compañía creció un 121% a 17,8 millones de dólares. Sin embargo, HeartCore registró una pérdida de valor de 7,2 millones de dólares relacionada con su filial Sigmaways, lo que resultó en una pérdida neta de 5,2 millones de dólares para el año.

La empresa mantuvo su liderazgo en el mercado japonés por noveno año consecutivo e implementó varias iniciativas estratégicas, incluyendo la expansión de su plataforma CMS a un modelo SaaS y la transición a contratos de varios años. HeartCore planea expandir su negocio de consultoría Go IPO a Corea del Sur, con un seminario programado para septiembre de 2025.

La empresa cerró 2024 con 2,1 millones de dólares en efectivo y equivalentes, en comparación con 1,0 millón de dólares en 2023, y reportó un EBITDA ajustado de 7,3 millones de dólares en comparación con (3,6) millones de dólares del año anterior.

HeartCore Enterprises (HTCR)� 2024� 재무 결과� 발표하며 39%� 수익 증가� 기록하여 3�4백만 달러� 달한다고 전했습니�. 회사� � 이익은 121% 증가하여 1�7�8십만 달러� 달했습니�. 그러� HeartCore� Sigmaways 자회사와 관련하� 720� 달러� 영업� 손실� 기록하여 연간 520� 달러� 순손실을 입었습니�.

회사� 일본에서 아홉 번째 연속으로 시장 리더십을 유지했으�, SaaS 모델� CMS 플랫폼을 확장하고 다년 계약으로 전환하는 � 여러 전략� 이니셔티브를 시행했습니다. HeartCore� 2025� 9월에 예정� 세미나를 통해 한국으로 Go IPO 컨설� 사업� 확장� 계획입니�.

회사� 2024년을 210� 달러� 현금 � 현금� 자산으로 마감했으�, 이는 2023년의 100� 달러에서 증가� 수치입니�. 또한 조정� EBITDA� 전년� (360� 달러) 대� 730� 달러� 보고되었습니�.

HeartCore Enterprises (HTCR) a publié ses résultats financiers pour 2024, montrant une augmentation des revenus de 39% à 30,4 millions de dollars par rapport à l'année précédente. Le bénéfice brut de l'entreprise a augmenté de 121% pour atteindre 17,8 millions de dollars. Cependant, HeartCore a enregistré une dépréciation de goodwill de 7,2 millions de dollars liée à sa filiale Sigmaways, entraînant une perte nette de 5,2 millions de dollars pour l'année.

L'entreprise a maintenu sa position de leader sur le marché japonais pour la neuvième année consécutive et a mis en œuvre plusieurs initiatives stratégiques, notamment l'expansion de sa plateforme CMS vers un modèle SaaS et la transition vers des contrats pluriannuels. HeartCore prévoit d'étendre son activité de conseil Go IPO en Corée du Sud, avec un séminaire prévu pour septembre 2025.

L'entreprise a terminé 2024 avec 2,1 millions de dollars en liquidités et équivalents, en hausse par rapport à 1,0 million de dollars en 2023, et a déclaré un EBITDA ajusté de 7,3 millions de dollars par rapport à (3,6) millions de dollars l'année précédente.

HeartCore Enterprises (HTCR) hat seine finanziellen Ergebnisse für 2024 veröffentlicht und einen Umsatzanstieg von 39% auf 30,4 Millionen Dollar im Vergleich zum Vorjahr verzeichnet. Der Bruttogewinn des Unternehmens stieg um 121% auf 17,8 Millionen Dollar. Allerdings verzeichnete HeartCore eine Wertminderung des Goodwills in Höhe von 7,2 Millionen Dollar, die mit seiner Tochtergesellschaft Sigmaways verbunden ist, was zu einem Nettoverlust von 5,2 Millionen Dollar für das Jahr führte.

Das Unternehmen behauptete seine Marktführerschaft in Japan im neunten Jahr in Folge und setzte mehrere strategische Initiativen um, darunter die Erweiterung seiner CMS-Plattform auf ein SaaS-Modell und den Übergang zu mehrjährigen Verträgen. HeartCore plant, sein Go IPO-Beratungsunternehmen nach Südkorea auszudehnen, mit einem Seminar, das für September 2025 angesetzt ist.

Das Unternehmen schloss das Jahr 2024 mit 2,1 Millionen Dollar in Bargeld und liquiden Mitteln ab, was einem Anstieg von 1,0 Millionen Dollar im Jahr 2023 entspricht, und berichtete von einem bereinigten EBITDA von 7,3 Millionen Dollar im Vergleich zu (3,6) Millionen Dollar im Vorjahr.

Positive
  • Revenue increased 39% to $30.4 million
  • Gross profit grew 121% to $17.8 million
  • Adjusted EBITDA improved to $7.3 million from $(3.6) million
  • Cash position doubled to $2.1 million from $1.0 million
  • Maintained top market share in Japan for 9th consecutive year
  • Transition to multi-year contracts from annual agreements
Negative
  • $7.2 million impairment of goodwill related to Sigmaways subsidiary
  • Net loss of $5.2 million for 2024
  • Operating expenses increased 46% to $17.8 million
  • Net loss attributable to HeartCore of $1.5 million

Insights

HeartCore's 2024 results present a mixed but generally improving financial picture. The 39% revenue increase to $30.4 million alongside a 121% jump in gross profit to $17.8 million demonstrates significant top-line growth, primarily driven by successful Go IPO consulting service clients. The impressive $7.3 million adjusted EBITDA (versus -$3.6 million last year) represents a dramatic operational improvement when excluding one-time impairments.

However, the $7.2 million impairment charge related to Sigmaways acquisition resulted in a net loss of $5.2 million, though losses attributable to HeartCore improved to $1.5 million from $4.2 million. Management's characterization of this as a one-time event appears reasonable given the corrective measures implemented, including separating Sigmaways' liabilities and suspending certain transactions.

The company's strategic pivot toward multi-year agreements, SaaS delivery models, and international expansion of its Go IPO business (particularly into South Korea) establishes promising growth vectors. The doubling of cash reserves to $2.1 million strengthens their financial position, though this remains modest relative to their revenue and acquisition ambitions. The articulated M&A strategy focusing on complementary technologies to increase wallet share within their existing 1,000+ enterprise customer base presents a pragmatic approach to sustained growth.

NEW YORK and TOKYO, March 31, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore� or the “Company�), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the year ended December 31, 2024.

Recent Operational & Financial Highlights

  • 2024 revenue increased 39% to $30.4 million year-over-year
  • HeartCore recorded $7.2 million in impairment of goodwill and intangible asset related to acquisition of its subsidiary Sigmaways. The losses are considered as a one-time occurrence that will not affect the Company’s business and financial performance in the future quarters.
  • new business development team aimed at strengthening customer success across HeartCore’s CMS business
  • plans to expand the Go IPO consulting business into South Korea. The Company adjusted its scheduled South Korea IPO seminar event to September 2025
  • new digital customer experience initiatives and cross-selling efforts
  • compliance with Nasdaq’s continued listing requirements
  • CMS platform offering into a SaaS delivery model
  • into a sales collaboration with Tosho Computer Systems Co., Ltd.
  • transition from annual contracts to multi-year agreements for core software business contracts
  • with NTT Data Business Brains Corporation to enhance website development service capabilities
  • top market share in Japan for nine consecutive years
  • new contract from Fourmix Co., Ltd. to implement CMS platform

Management Commentary
HeartCore CEO Sumitaka Kanno commented: “Over the past year, we made several strategic advancements in our software business model, all aimed at driving sustainable and predictable revenue growth, improving margins, and enhancing our ability to effectively cross-sell and upsell to our 1,000+ enterprise customers. While we are confident that the initiatives we have implemented will yield meaningful returns, we have also recognized that strategic acquisitions will be critical to maintaining our market leadership in Japan and sustaining our strong customer retention rate. With a well-established customer base built over the years, our acquisition strategy will primarily focus on deepening wallet share with each client we are engaged with, while seamlessly complementing and enhancing our existing suite of software solutions. This will include acquiring companies with synergistic technologies that align with our core offerings and leveraging effective use of AI to strengthen our value proposition and competitive edge. Outside of acquisitions, another key focus for HeartCore will be to accelerate the development of new products geared for global expansion in 2025, with the target launch aimed for the first half of 2026. Currently, only a small portion of our customer base consists of enterprises outside of Japan. By focusing on creating globally scalable solutions and enhancing our offerings with synergistic technologies through strategic acquisitions, we aim to expand our presence across international markets and drive additional growth in our software business.

“Looking at our financial performance, we recorded approximately $7.2 million in impairment of goodwill and intangible asset, primarily related to our subsidiary, Sigmaways. While these losses impacted our full-year results, they are classified as one-time occurrences and are not expected to affect our financial performance in future quarters. To address this, we have already implemented several corrective measures, including separating Sigmaways� liabilities and suspending all transactions with small venture companies to minimize any non-essential costs. While net loss for the year was $5.2 million, we believe a more relevant measure of our performance is adjusted EBITDA, which totaled $7.3 million for 2024, as it excludes the losses related to Sigmaways. Nevertheless, our subsidiaries continue to deliver synergistic technologies that enable us to effectively upsell and cross-sell to our shared clients. We believe that over the long term, as we continue to develop and innovate our solutions, acquire new technologies through M&A, and tap into mutual client portfolios across our partners and subsidiaries, we will drive positive outcomes for our financial performance.

“Outside of exploring synergistic M&A opportunities within our software business to fuel growth, we are also focused on expanding our Go IPO business. We recently announced our plans to extend our service into South Korea and have formed a strategic partnership with a venture fund in the region. To kick off this initiative, we will be hosting a seminar in September of this year. South Korea will be the first of several markets we aim to expand into across the APAC region, as IPO interests from foreign issuers have steadily increased over the years. Expanding beyond Japan’s borders marks a significant milestone for our Go IPO business, opening up new opportunities for us to leverage. To ensure successful market entry, we are actively seeking strategic partnerships, such as in South Korea, to gain access to their clientele portfolio that are interested in our services. We remain dedicated to executing both lines of business and look forward to our growth prospects throughout 2025.�

2024 Financial Results
Revenues increased 39% to $30.4 million, compared to $21.8 million in the same period last year. The increase was primarily due to revenue from warrants and ordinary shares associated with the successful listing of two Go IPO consulting service clients.

Gross profit increased 121% to $17.8 million, compared to $8.1 million in the same period last year. The increase was primarily due to the aforementioned reason.

Operating expenses increased 46% to $17.8 million, compared to $12.2 million in the same period last year. The increase was primarily due to impairment of goodwill and intangible asset totaling approximately $7.2 million primarily related to our subsidiary, Sigmaways. The Company anticipates these impairment losses to be a one-time occurrence and does not foresee any material impact on its financial performance in future quarters.

Net loss for 2024 was $5.2 million. Net loss attributable to HeartCore improved to $1.5 million, compared to a loss of $4.2 million in the same period last year.

Adjusted EBITDA for the year totaled $7.3 million compared to $(3.6) million in the same period last year.

As of December 31, 2024, the Company had cash and cash equivalents of $2.1 million, compared to $1.0 million on December 31, 2023.

About HeartCore Enterprises, Inc.
Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading enterprise software and consulting services company. HeartCore offers Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore’s customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. HeartCore’s GO IPOSM consulting services helps Japanese-based companies go public in the U.S. Additional information about the Company's products and services is available at and .

Non-GAAP Financial Measures Disclaimer
This document includes references to adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, adjusted EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, impairment of intangible asset, and impairment of goodwill.

This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP.

Management believes that this adjusted EBITDA provides useful information to investors by highlighting the company’s core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.

ItemFY24FY23
Net Loss-$5.2 million-$4.9 million
(+) Depreciation$0.1 million$0.1 million
(+) Impairment loss on goodwill$3.3 million$0.0 million
(+) Impairment loss on intangible assets$3.9 million$0.0 million
(+) Changes in fair value of investments in marketable securities$2.4 million$0.6 million
(+) Changes in fair value of investment in warrants-$1.7 million$0.5 million
(+) Loss on sale of warrants$4.0 million$0.0 million
(+) Impairment of investment in equity securities$0.3 million$0.0 million
(+) Loss on forgiveness of note receivable$0.1 million$0.0 million
(+) Interest income$0.0 million-$0.1 million
(+) Interest expenses$0.1 million$0.2 million
(+) Government grants$0.0 million-$0.1 million
Adjusted EBITDA$7.3 million-$3.6 million

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,� “intend,� “expect,� “anticipate,� “plan,� “potential,� “continue,� or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

HeartCore Investor Relations Contact:
Gateway Group, Inc.
Matt Glover and John Yi
[email protected]
(949) 574-3860

HeartCore Enterprises, Inc.
Consolidated Balance Sheets
December 31,December 31,
20242023
ASSETS
Current assets:
Cash and cash equivalents$2,121,089$1,012,479
Accounts receivable1,950,0502,623,682
Investments in marketable securities4,495,703642,348
Investment in equity securities-300,000
Prepaid expenses458,839536,865
Current portion of long-term note receivable100,000100,000
Due from related party40,13944,758
Other current assets251,545234,761
Total current assets9,417,3655,494,893
Non-current assets:
Accounts receivable, non-current752,930-
Property and equipment, net584,854763,730
Operating lease right-of-use assets1,936,0972,467,889
Intangible asset, net-4,515,625
Goodwill-3,276,441
Long-term investment in warrants577,7862,004,308
Long-term note receivable100,000200,000
Deferred tax assets152,300369,436
Security deposits307,996348,428
Long-term loan receivable from related party123,928182,946
Other non-current assets11,77871
Total non-current assets4,547,66914,128,874
Total assets$13,965,034$19,623,767
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses$2,039,323$1,757,038
Accounts payable and accrued expenses - related party47,199-
Accrued payroll and other employee costs675,502723,305
Due to related parties9321,476
Short-term debt-135,937
Short-term debt - related party75,000-
Current portion of long-term debts401,255371,783
Insurance premium financing16,626-
Factoring liability172,394562,767
Operating lease liabilities, current371,951396,535
Finance lease liabilities, current15,95617,445
Income tax payables822,014162,689
Deferred revenue1,876,4902,166,175
Other current liabilities907,080216,405
Total current liabilities7,421,7226,511,555
Non-current liabilities:
Long-term debts1,238,8131,770,352
Operating lease liabilities, non-current1,614,9962,135,160
Finance lease liabilities, non-current43,59366,779
Deferred tax liabilities-1,264,375
Other non-current liabilities183,895208,732
Total non-current liabilities3,081,2975,445,398
Total liabilities10,503,01911,956,953
Shareholders' equity:
Preferred shares ($0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding as of December 31, 2024 and 2023)--
Common shares ($0.0001 par value, 200,000,000 shares authorized; 21,937,987 and 20,842,690 shares issued and outstanding as of December 31, 2024 and 2023, respectively)2,1932,083
Subscription receivable(103,942)-
Additional paid-in capital20,656,15319,594,801
Accumulated deficit(16,244,843)(14,763,469)
Accumulated other comprehensive income343,936331,881
Total HeartCore Enterprises, Inc. shareholders' equity4,653,4975,165,296
Non-controlling interests(1,191,482)2,501,518
Total shareholders' equity3,462,0157,666,814
Total liabilities and shareholders' equity$13,965,034$19,623,767



HeartCore Enterprises, Inc.
Consolidated Statements of Operations and Comprehensive Loss
For the year ended December 31,2024 For the year ended December 31,2023
Revenues$30,407,229$21,845,830
Cost of revenues12,579,35913,778,416
Gross profit17,827,8708,067,414
Operating expenses:
Selling expenses1,255,3681,516,247
General and administrative expenses8,623,5879,651,381
Research and development expenses729,5841,019,141
Impairment of intangible asset3,878,125-
Impairment of goodwill3,276,441-
Total operating expenses17,763,10512,186,769
Income (loss) from operations64,765(4,119,355)
Other income (expenses):
Changes in fair value of investments in marketable securities(2,412,385)(615,520)
Changes in fair value of investment in warrants1,657,699(501,445)
Loss on sale of warrants(3,970,628)-
Impairment of investment in equity securities(300,000)-
Loss on forgiveness of note receivable(100,000)-
Interest income18,83570,624
Interest expenses(144,033)(162,968)
Government grants-76,612
Other income260,918366,283
Other expenses(424,893)(124,595)
Total other expenses(5,414,487)(891,009)
Loss before income tax benefit(5,349,722)(5,010,364)
Income tax benefit(136,822)(133,664)
Net loss(5,212,900)(4,876,700)
Less: net loss attributable to non-controlling interests(3,731,526)(686,810)
Net loss attributable to HeartCore Enterprises, Inc.$(1,481,374)$(4,189,890)
Other comprehensive loss:
Foreign currency translation adjustment(16,614)(34,628)
Total comprehensive loss(5,229,514)(4,911,328)
Less: comprehensive loss attributable to non-controlling interests(3,760,195)(688,482)
Comprehensive loss attributable to HeartCore Enterprises, Inc.$(1,469,319)$(4,222,846)
Net loss per common share attributable to HeartCore Enterprises, Inc.
Basic$(0.07)$(0.21)
Diluted$(0.07)$(0.21)
Weighted average common shares outstanding
Basic20,940,95620,404,642
Diluted20,940,95620,404,642



HeartCore Enterprises, Inc.
Consolidated Statements of Cash Flows
For the year ended December 31,2024For the year ended December 31, 2023
Cash flows from operating activities:
Net loss$(5,212,900)$(4,876,700)
Adjustments to reconcile net loss to net cash flows
used in operating activities:
Depreciation and amortization expenses749,639683,019
Loss (gain) on disposal of property and equipment1,894(4,514)
Amortization of debt issuance costs4,5673,733
Non-cash lease expense365,531346,070
Loss (gain) on termination of lease(469)76
Impairment of intangible asset3,878,125-
Impairment of goodwill3,276,441-
Deferred income taxes(1,076,600)(291,596)
Stock-based compensation368,7441,430,513
Marketable securities received as noncash consideration(572,010)-
Warrants received as noncash consideration(12,969,683)(3,763,621)
Changes in fair value of investments in marketable securities2,412,385615,520
Changes in fair value of investment in warrants(1,657,699)501,445
Loss on sale of warrants3,970,628-
Impairment of investment in equity securities300,000-
Impairment of investment in SAFE75,000-
Loss on forgiveness of note receivable100,000-
Changes in assets and liabilities:
Accounts receivable(193,369)(338,312)
Prepaid expenses210,477359,310
Other assets(38,336)(133,550)
Accounts payable and accrued expenses331,685532,790
Accounts payable and accrued expenses - related party47,955-
Accrued payroll and other employee costs3,623152,101
Due to related parties(1,338)1,123
Operating lease liabilities(371,877)(327,877)
Income tax payables669,142162,045
Deferred revenue(156,527)553,130
Other liabilities710,00164,086
Net cash flows used in operating activities(4,774,971)(4,331,209)
Cash flows from investing activities:
Purchases of property and equipment(7,446)(526,260)
Proceeds from disposal of property and equipment-24,814
Advance on note receivable-(600,000)
Purchase of investment in SAFE(75,000)-
Net proceeds from sale of warrants5,640,000-
Proceeds from sale of marketable securities749,546-
Repayment of loan provided to related party42,10445,404
Payment for acquisition of subsidiary, net of cash acquired-(724,910)
Net cash flows provided by (used in) investing activities6,349,204(1,780,952)
Cash flows from financing activities:
Payments for finance leases(16,766)(22,422)
Proceeds from short-term and long-term debts68,138710,107
Proceeds from related party debt75,000-
Repayment of short-term and long-term debts(554,553)(711,395)
Repayment of insurance premium financing(156,063)(389,035)
Net proceeds from factoring arrangement-562,767
Net repayment of factoring arrangement(390,373)-
Payments for debt issuance costs-(13,828)
Distribution of dividends(834,566)-
Capital contribution from non-controlling shareholder67,195-
Proceeds from issuance of common shares1,423,342-
Net cash flows provide by (used in) financing activities(318,646)136,194
Effect of exchange rate changes(146,977)(188,880)
Net change in cash and cash equivalents1,108,610(6,164,847)
Cash and cash equivalents - beginning of the year1,012,4797,177,326
Cash and cash equivalents - end of the year$2,121,089$1,012,479
Supplemental cash flow disclosures:
Interest paid$143,101$85,634
Income taxes paid$298,466$91,707
Non-cash investing and financing transactions
Finance lease right-of-use assets obtained in exchange for finance lease liabilities$-$93,217
Operating lease right-of-use assets obtained in exchange for operating lease liabilities$125,735$317,040
Remeasurement of operating lease liabilities and right-of-use assets due to lease modification$23,956$30,186
Insurance premium financing$172,689$389,035
Common shares issued for acquisition of subsidiary$-$3,150,000
Warrants converted to marketable securities$6,443,276$1,257,868
Note receivable converted to investment in equity securities$-$300,000

FAQ

What was HeartCore's (HTCR) revenue growth in 2024?

HeartCore's revenue grew 39% to $30.4 million in 2024 compared to $21.8 million in 2023.

How much was HTCR's goodwill impairment in 2024?

HeartCore recorded $7.2 million in impairment of goodwill and intangible assets, primarily related to its Sigmaways subsidiary.

What is HeartCore's (HTCR) expansion plan for its Go IPO business?

HeartCore plans to expand its Go IPO consulting business into South Korea, with a seminar scheduled for September 2025, as the first step into the APAC region.

What strategic changes did HTCR make to its software business model in 2024?

HeartCore expanded its CMS platform to a SaaS delivery model and transitioned from annual to multi-year contracts for core software business.

What was HeartCore's (HTCR) cash position at the end of 2024?

HeartCore had $2.1 million in cash and cash equivalents as of December 31, 2024, up from $1.0 million in 2023.
HEARTCORE ENTERPRISES INC

NASDAQ:HTCR

HTCR Rankings

HTCR Latest News

HTCR Latest SEC Filings

HTCR Stock Data

12.14M
6.52M
75.35%
2.93%
0.11%
Software - Application
Services-computer Processing & Data Preparation
Japan
TOKYO